Ameritas Investment Company’s VivoSim Labs VIVS Stock Holding History

Ameritas Investment Company’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2	Closed	–	–	1651
2020 Q1	$0	Buy	+2	New	+$161	﹤0.01%	1844
2019 Q4	–	Sell	-2	Closed	–	–	1553
2019 Q3	$0	Buy	+2	New	+$168	﹤0.01%	1665
2019 Q2	–	Sell	-2	Closed	–	–	914
2019 Q1	$0	Buy	+2	New	+$504	﹤0.01%	1815

Other funds holding VIVS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Ameritas Investment Company's VIVS Position: Q2 2020 in Review

Ameritas Investment Company sold out of VivoSim Labs (VIVS) in Q2 2020, closing a stake of 2 shares.

Ameritas Investment Company first reported a position in VIVS in Q1 2019 and held it in 3 quarters. The position peaked at $0 in Q1 2020. 72 funds tracked by Wall St. Rank hold VIVS as of Q2 2020.

Ameritas Investment Company reported no remaining VivoSim Labs position as of Q2 2020 after selling out during the quarter.
Ameritas Investment Company sold 2 VivoSim Labs shares in Q2 2020.
Ameritas Investment Company first reported a position in VivoSim Labs in Q1 2019 and held it in 3 quarters.
Ameritas Investment Company's VivoSim Labs position peaked at $0 in Q1 2020.
72 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2020.

Based on Ameritas Investment Company's 13F filing for Q2 2020, filed 14 Aug 2020.